Archives

Major Depressive Disorder In Chronic Kidney Disease
Major depressive disorder (MDD) affects more than 260 million people worldwide. The reported prevalence of depression in patients with chronic kidney disease (CKD) ranges from 20-65%. This presentation provides an overview of both MDD and CKD and discusses their overlap of symptomology.
*Drs Green and DiNapoli are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC).
Featured Speakers

Jill A. Green, PhD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Jill A Green, PhD, is a Medical Science Director in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.
Dr Green has been a proud member of the PKD Foundation – Columbus, Ohio chapter for over 12 years where she has been active in fundraising and advocacy efforts.

Beth DiNapoli, PhD
Otsuka Pharmaceutical Development & Commercialization, Inc.*
Areas of Expertise: Geriatric Mental Health, Mood Disorders, Cognitive Behavioral Therapy
Prior Experience: Project Manager, Visiting Instructor, Patient Care & Mental Health Service Provider
Schools Attended: University of Alabama (Tuscaloosa, AL), Claremont McKenna College (Claremont, CA)
Fellowships, Internships, & Residencies: Clinical Psychology Internship, Baylor College of Medicine (Houston, TX), Postdoctoral Fellowship, VA Pittsburgh Healthcare System (Pittsburgh, PA)
Location:
Jag’s Steak & Seafood (West Chester)
West Chester Township, Ohio 45069 United States + Google Map